Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    23339726 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Condition: Hypertension
Interventions: Drug: Aliskiren;   Drug: Valsartan;   Drug: Placebo for Aliskiren;   Drug: Placebo for Valsartan
To Top

† Indicates status has not been verified in more than two years